Value of artificial intelligence in neuro-oncology.

No abstract is available for this paper.

• Publication year

  2025

• Venue

  The Lancet Digital Health

• Publication date

  2025-08-08

• Fields of study

  Medicine, Computer Science

• Identifiers
  DOI 10.1016/j.landig.2025.100876PMID 40783350PMCID PMC12338051
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 2: recommendations for standardisation, validation, and good clinical practice.

  2024cited by this paper
• US FDA Approval of Pediatric Artificial Intelligence and Machine Learning–Enabled Medical Devices

  2024cited by this paper
• Integrated electrophysiological and genomic profiles of single cells reveal spiking tumor cells in human glioma.

  2024cited by this paper
• Deep Learning Segmentation of Infiltrative and Enhancing Cellular Tumor on Pre- and Posttreatment Multishell Diffusion MRI of Glioblastoma.

  2024cited by this paper
• Enhancing neuro-oncology care through equity-driven applications of artificial intelligence.

  2024cited by this paper
• A prognostic neural epigenetic signature in high-grade glioma

  2024cited by this paper
• Dose-Incorporated Deep Ensemble Learning for Improving Brain Metastasis SRS Outcome Prediction.

  2024cited by this paper
• Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer Programme

  2024cited by this paper
• Foundation models for fast, label-free detection of glioma infiltration

  2024cited by this paper
• Machine learning identifies experimental brain metastasis subtypes based on their influence on neural circuits

  2023cited by this paper
• Single-cell transcriptomic analyses provide insights into the cellular origins and drivers of brain metastasis from lung adenocarcinoma

  2023cited by this paper
• Proteogenomics of diffuse gliomas reveal molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms

  2023cited by this paper
• Integrative multi-omics networks identify PKCδ and DNA-PK as master kinases of glioblastoma subtypes and guide targeted cancer therapy

  2023cited by this paper
• Cancer hallmarks intersect with neuroscience in the tumor microenvironment

  2023cited by this paper
• Artificial-intelligence-based molecular classification of diffuse gliomas using rapid, label-free optical imaging

  2023cited by this paper
• Cancer neuroscience: State of the field, emerging directions.

  2023cited by this paper
• Novel Mechanisms and Future Opportunities for the Management of Radiation Necrosis in Patients Treated for Brain Metastases in the Era of Immunotherapy

  2023cited by this paper
• Glioblastoma remodelling of human neural circuits decreases survival

  2023cited by this paper
• Radiomics for the non-invasive prediction of PD-L1 expression in patients with brain metastases secondary to non-small cell lung cancer

  2023cited by this paper
• Machine learning for cryosection pathology predicts the 2021 WHO classification of glioma.

  2023cited by this paper
• Depth of radiographic response (DpR) and time to tumor regrowth (TTG) predicts overall survival following anti-VEGF therapy in recurrent glioblastoma.

  2023cited by this paper
• National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities.

  2023cited by this paper
• Scientific discovery in the age of artificial intelligence

  2023cited by this paper
• Rapid intraoperative multi-molecular diagnosis of glioma with ultrasound radio frequency signals and deep learning

  2023cited by this paper
• A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 co-altered: a clinico-radiological and histomolecular characterisation

  2023cited by this paper
• A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups.

  2023cited by this paper
• Ultra-fast deep-learned CNS tumour classification during surgery

  2023cited by this paper
• Neuropathologist-level integrated classification of adult-type diffuse gliomas using deep learning from whole-slide pathological images

  2023cited by this paper
• Investigational treatment strategies in glioblastoma: progress made and barriers to success

  2023cited by this paper
• Spatial cellular architecture predicts prognosis in glioblastoma

  2023cited by this paper
• Primary brain tumours in adults.

  2023cited by this paper
• Mitigating Radiotoxicity in the Central Nervous System: Role of Proton Therapy

  2023cited by this paper
• Noninvasive radiomics model reveals macrophage infiltration in glioma.

  2023cited by this paper
• Automated Tumor Segmentation in Radiotherapy.

  2022cited by this paper
• Evaluating robotic pedicle screw placement against conventional modalities: a systematic review and network meta-analysis.

  2022cited by this paper
• Topographic mapping of the glioblastoma proteome reveals a triple-axis model of intra-tumoral heterogeneity

  2022cited by this paper
• Advances in local therapy for glioblastoma — taking the fight to the tumour

  2022cited by this paper
• Cerebrovascular Dysregulation in Patients with Glioma Assessed with Time-shifted BOLD fMRI.

  2022cited by this paper
• Paying for artificial intelligence in medicine

  2022cited by this paper
• Deep learning super-resolution magnetic resonance spectroscopic imaging of brain metabolism and mutant isocitrate dehydrogenase glioma

  2022cited by this paper
• Clinical Significance and Molecular Annotation of Cellular Morphometric Subtypes in Lower Grade Gliomas discovered by Machine Learning.

  2022cited by this paper
• Combined molecular subtyping, grading, and segmentation of glioma using multi-task deep learning

  2022cited by this paper
• Brain radiotoxicity-related 15CAcBRT gene expression signature predicts survival prognosis of glioblastoma patients

  2022cited by this paper
• DNA methylation-based epigenetic signatures predict somatic genomic alterations in gliomas

  2022cited by this paper
• AI-based decision support improves reproducibility of tumor response assessment in neuro-oncology: an international multi-reader study.

  2022cited by this paper
• Development and Validation of a Deep Learning Model for Brain Tumor Diagnosis and Classification Using Magnetic Resonance Imaging

  2022cited by this paper
• Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group

  2022cited by this paper
• Machine learning-based tumor-infiltrating immune cell-associated lncRNAs for predicting prognosis and immunotherapy response in patients with glioblastoma

  2022cited by this paper
• Semantic reconstruction of continuous language from non-invasive brain recordings

  2022cited by this paper
• Characterizing the biology of primary brain tumors and their microenvironment via single-cell profiling methods

  2022cited by this paper
• Pediatric spinal pilocytic astrocytomas form a distinct epigenetic subclass from pilocytic astrocytomas of other locations and diffuse leptomeningeal glioneuronal tumours

  2022cited by this paper
• Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1

  2022cited by this paper
• Large language models encode clinical knowledge

  2022cited by this paper
• A deep learning model for discriminating true progression from pseudoprogression in glioblastoma patients

  2022cited by this paper
• Precision Radiotherapy for Gliomas

  2021cited by this paper
• Deep learning of magnetic resonance fingerprints for the quantitative imaging of apoptosis following oncolytic virotherapy

  2021cited by this paper
• Automated operative workflow analysis of endoscopic pituitary surgery using machine learning: development and preclinical evaluation (IDEAL stage 0).

  2021cited by this paper
• Pan-cancer analysis of non-coding transcripts reveals the prognostic onco-lncRNA HOXA10-AS in gliomas.

  2021cited by this paper
• Improving the noninvasive classification of glioma genetic subtype with deep learning and diffusion-weighted imaging.

  2021cited by this paper
• Deep learning features from diffusion tensor imaging improve glioma stratification and identify risk groups with distinct molecular pathway activities

  2021cited by this paper
• Biologic Pathways Underlying Prognostic Radiomics Phenotypes from Paired MRI and RNA Sequencing in Glioblastoma.

  2021cited by this paper
• Neuroprosthesis for Decoding Speech in a Paralyzed Person with Anarthria.

  2021cited by this paper
• The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.

  2021cited by this paper
• 18F-FDOPA PET for the Noninvasive Prediction of Glioma Molecular Parameters: A Radiomics Study

  2021cited by this paper
• High-performance brain-to-text communication via handwriting

  2021cited by this paper
• Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients

  2021cited by this paper
• Response assessment during chemoradiation using a hypercellular/hyperperfused imaging phenotype predicts survival in patients with newly diagnosed glioblastoma.

  2021cited by this paper
• The Biological Meaning of Radiomic Features.

  2021cited by this paper
• Can Deep Learning Replace Gadolinium in Neuro-Oncology?

  2021cited by this paper
• Feasibility of Simulated Postcontrast MRI of Glioblastomas and Lower-Grade Gliomas by Using Three-dimensional Fully Convolutional Neural Networks.

  2021cited by this paper
• Artificial intelligence in radiation oncology

  2020cited by this paper
• From Real‐World Patient Data to Individualized Treatment Effects Using Machine Learning: Current and Future Methods to Address Underlying Challenges

  2020cited by this paper
• EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

  2020cited by this paper
• Functional analysis of low-grade glioma genetic variants predicts key target genes and transcription factors.

  2020cited by this paper
• Global, regional, and national burden of brain and other CNS cancer, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

  2019cited by this paper
• Epidemiology of Brain Metastases

  2012cited by this paper
• Advancing neurosurgery with image-guided robotics.

  2009cited by this paper

• Vision and Multimodal Foundation Models in Medical Imaging: A Comprehensive Review of Architectures, Clinical Trends, and Future Directions

  2026influential citation
• Speed meets precision: rapid intraoperative diagnostics in neuro-oncologic surgery.

  2026cites this paper
• Leading artificial intelligence-driven drug discovery platforms: 2025 landscape and global outlook.

  2025cites this paper
• Comparative review of stimulated Raman histology applications in pediatric and adult glioma surgery

  2025cites this paper
• Artificial Intelligence in Neuro-Oncology: Applications in Diagnosis, Prognosis and Treatment

  2025cites this paper